Xspray Pharma AB (publ) (STO:XSPRAY)
10.18
-0.30 (-2.86%)
Nov 20, 2026, 5:29 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 482.7 million as of November 20, 2026. It is the 29,902nd most valuable company in the world and the 391st biggest in Sweden. Its market cap has decreased by 54.02% in one year.
Market Cap
482.70M
Enterprise Value
490.20M
Revenue
7.19M
Global Rank
Country Rank
#391 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 482.70M, an increase of 28.48%. That is a compound annual growth rate of 2.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 482.70M | -63.23% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 934.92M |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |
| Oncopeptides AB | 648.27M |
| FluoGuide | 482.30M |
| Sprint Bioscience AB | 388.30M |
| Corline Biomedical AB | 365.86M |